ezlopitant has been researched along with deuterium in 2 studies
Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (deuterium) | Trials (deuterium) | Recent Studies (post-2010) (deuterium) |
---|---|---|---|---|---|
22 | 2 | 1 | 13,104 | 217 | 2,527 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Obach, RS | 1 |
Kamel, AM; Massefski, WW; Zandi, KS | 1 |
2 other study(ies) available for ezlopitant and deuterium
Article | Year |
---|---|
Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs.
Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Catalysis; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deuterium; Isotope Labeling; Kinetics; Mixed Function Oxygenases; Neurokinin-1 Receptor Antagonists; Recombinant Proteins | 2001 |
Identification of the degradation product of ezlopitant, a non-peptidic substance P antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy.
Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Deuterium; Magnetic Resonance Spectroscopy; Protons; Spectrometry, Mass, Electrospray Ionization; Substance P | 2003 |